SFRP4 and prostate carcinoma: Leveraging spatial and bulk transcriptomics, DNA methylomics and proteomics on the same prostate cancer tissue samples, this study provides insights on the tissue origin and role of SFRP4 gene expression in aggressive prostate cancer.